Trupanion, Inc. (NASDAQ:TRUP – Get Free Report) CFO Fawwad Qureshi sold 4,645 shares of the company’s stock in a transaction dated Wednesday, February 25th. The stock was sold at an average price of $25.61, for a total value of $118,958.45. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link.
Trupanion Price Performance
Shares of TRUP traded down $0.70 during trading hours on Friday, reaching $26.54. 372,424 shares of the company’s stock traded hands, compared to its average volume of 617,031. Trupanion, Inc. has a 12 month low of $25.24 and a 12 month high of $57.88. The company has a current ratio of 1.69, a quick ratio of 1.69 and a debt-to-equity ratio of 0.27. The stock has a market cap of $1.15 billion, a PE ratio of 58.98 and a beta of 1.58. The firm’s 50 day simple moving average is $32.95 and its 200-day simple moving average is $38.69.
Trupanion (NASDAQ:TRUP – Get Free Report) last posted its quarterly earnings data on Thursday, February 12th. The financial services provider reported $0.13 earnings per share for the quarter, missing the consensus estimate of $0.14 by ($0.01). Trupanion had a return on equity of 5.39% and a net margin of 1.35%.The company had revenue of $376.85 million during the quarter, compared to the consensus estimate of $375.89 million. During the same quarter last year, the company posted $0.04 earnings per share. The firm’s revenue for the quarter was up 11.7% on a year-over-year basis. Equities analysts expect that Trupanion, Inc. will post 0.13 EPS for the current year.
Institutional Investors Weigh In On Trupanion
Wall Street Analyst Weigh In
Several research analysts recently issued reports on the stock. Wall Street Zen lowered shares of Trupanion from a “buy” rating to a “hold” rating in a research report on Saturday, December 6th. Cantor Fitzgerald dropped their price target on Trupanion from $50.00 to $42.00 and set a “neutral” rating for the company in a research note on Wednesday, January 14th. Zacks Research lowered Trupanion from a “strong-buy” rating to a “hold” rating in a research report on Friday, February 13th. Weiss Ratings raised Trupanion from a “sell (d+)” rating to a “hold (c-)” rating in a report on Tuesday, February 17th. Finally, Stifel Nicolaus cut their target price on Trupanion from $38.00 to $35.00 and set a “hold” rating for the company in a research note on Friday, February 13th. Two equities research analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. According to MarketBeat, Trupanion has an average rating of “Hold” and an average price target of $45.50.
Get Our Latest Analysis on TRUP
About Trupanion
Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.
Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.
Featured Articles
- Five stocks we like better than Trupanion
- The gold chart Wall Street is terrified of…
- This makes me furious
- America’s 1776 happening again
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.
